Vivo Bio Tech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	514.24	466.73	454.51	522.3	513.91	517.75
Other Revenue	-42.41	-	0	-	-	-0
Revenue	471.83	466.73	454.51	522.3	513.91	517.75
Revenue Growth (YoY)	2.26%	2.69%	-12.98%	1.63%	-0.74%	-6.46%
Cost of Revenue	68.46	61.07	41.52	70.67	116.5	72.92
Gross Profit	403.37	405.65	412.99	451.64	397.41	444.83
Selling, General & Admin	231.67	200.56	202.09	236.62	239.27	268.21
Operating Expenses	332.87	290.73	295	329.27	313.73	324.12
Operating Income	70.49	114.93	118	122.36	83.67	120.71
Interest Expense	-60.54	-75.04	-77.78	-76.51	-39.93	-35.3
Interest & Investment Income	1.9	1.9	0.39	0.36	0.98	0.79
Other Non Operating Income (Expenses)	-0	-0	-	0	0	-
EBT Excluding Unusual Items	11.85	41.78	40.61	46.21	44.72	86.2
Gain (Loss) on Sale of Assets	46.15	46.15	-	-	-	-
Pretax Income	58	87.93	40.61	46.21	44.72	86.2
Income Tax Expense	12.84	15.1	15.34	19.72	22.71	29.37
Net Income	45.17	72.83	25.26	26.49	22.02	56.82
Net Income to Common	45.17	72.83	25.26	26.49	22.02	56.82
Net Income Growth	-35.07%	188.27%	-4.64%	20.33%	-61.26%	27.93%
Shares Outstanding (Basic)	19	15	15	15	14	13
Shares Outstanding (Diluted)	19	15	17	15	14	14
Shares Change (YoY)	15.62%	-8.33%	12.53%	4.66%	4.44%	5.23%
EPS (Basic)	2.34	4.76	1.70	1.79	1.56	4.23
EPS (Diluted)	2.34	4.76	1.51	1.78	1.56	4.19
EPS Growth	-43.83%	215.23%	-15.17%	14.33%	-62.84%	21.58%
Free Cash Flow	-	-104.42	75.72	108.36	-344.7	-86.46
Free Cash Flow Per Share	-	-6.83	4.54	7.31	-24.34	-6.38
Gross Margin	85.49%	86.91%	90.86%	86.47%	77.33%	85.92%
Operating Margin	14.94%	24.62%	25.96%	23.43%	16.28%	23.31%
Profit Margin	9.57%	15.60%	5.56%	5.07%	4.28%	10.97%
Free Cash Flow Margin	-	-22.37%	16.66%	20.75%	-67.07%	-16.70%
EBITDA	137.78	184.23	189.98	194.05	142.99	167.61
EBITDA Margin	29.20%	39.47%	41.80%	37.15%	27.82%	32.37%
D&A For EBITDA	67.29	69.3	71.98	71.68	59.32	46.9
EBIT	70.49	114.93	118	122.36	83.67	120.71
EBIT Margin	14.94%	24.62%	25.96%	23.43%	16.28%	23.31%
Effective Tax Rate	22.13%	17.18%	37.78%	42.67%	50.77%	34.08%
Revenue as Reported	519.88	514.77	454.9	522.66	514.89	518.54
Advertising Expenses	-	0.39	2.79	2.8	1.22	36.62

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.